Stuart A. Lipton
Affiliations: | Scripps Research Institute, La Jolla, La Jolla, CA, United States | ||
Neurosciences | University of California, San Diego, La Jolla, CA |
Area:
Neurodegenerative DiseaseWebsite:
https://www.scripps.edu/research/faculty/liptonGoogle:
"Stuart Lipton"Bio:
https://www.scripps.edu/lipton/members.html
Mean distance: 12.18 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentorJohn E. Dowling | grad student | 1977 | Harvard |
Torsten Wiesel | post-doc | Harvard Medical School |
Children
Sign in to add traineeJeffrey D. Zaremba | research assistant | 2007-2011 | Burnham Institute |
Scott D. Ryan | post-doc | 2011- | Sanford Burnham Research Institute |
Karthik Bodhinathan | post-doc | 2014- | Sanford-Burnham Medical Research Institute |
Swagata Ghatak | post-doc | 2016- | |
Elias Aizenman | post-doc | 1985-1987 | Harvard Medical School |
Thomas Goetz | post-doc | 2000-2003 | Burnham Institute |
Walid V. Soussou | post-doc | 2006-2008 | Burnham Institute for Medical Research |
Juan Pina-Crespo | research scientist | 2008-2015 | Sanford Burnham Institute |
Collaborators
Sign in to add collaboratorMichael M. Segal | collaborator | 1995-2002 | Children's Hospital and Harvard Medical School |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nakamura T, Oh CK, Liao L, et al. (2020) Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease. Science (New York, N.Y.) |
Ghatak S, Talantova M, Mckercher SR, et al. (2020) Novel Therapeutic Approach for Excitatory/Inhibitory Imbalance in Neurodevelopmental and Neurodegenerative Diseases. Annual Review of Pharmacology and Toxicology |
Ghatak S, Dolatabadi N, Gao R, et al. (2020) NitroSynapsin ameliorates hypersynchronous neural network activity in Alzheimer hiPSC models. Molecular Psychiatry |
Ghatak S, Dolatabadi N, Trudler D, et al. (2019) Mechanisms of hyperexcitability in Alzheimer's disease hiPSC-derived neurons and cerebral organoids vs. isogenic control. Elife. 8 |
Okamoto SI, Prikhodko O, Pina-Crespo J, et al. (2019) NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model. Neurobiology of Disease |
Trudler D, Lipton SA. (2019) Novel Direct Conversion of Microglia to Neurons. Trends in Molecular Medicine |
Mann AP, Scodeller P, Hussain S, et al. (2018) Publisher Correction: Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease. Nature Communications. 9: 1070 |
Ryan T, Bamm VV, Stykel MG, et al. (2018) Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein. Nature Communications. 9: 817 |
Oh CK, Sultan A, Platzer J, et al. (2017) S-Nitrosylation of PINK1 Attenuates PINK1/Parkin-Dependent Mitophagy in hiPSC-Based Parkinson's Disease Models. Cell Reports. 21: 2171-2182 |
Tu S, Akhtar MW, Escorihuela RM, et al. (2017) NitroSynapsin therapy for a mouse MEF2C haploinsufficiency model of human autism. Nature Communications. 8: 1488 |